Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc. (OTCPK:ATXI) through any online brokerage.
There are no as such competitors for AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc..
AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc. has a consensus price target of $0.75.
The stock price for AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc. (OTCPK: ATXI) is $0.28 last updated June 1, 2026 at 3:22 PM EDT.
There are no upcoming dividends for AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc..
AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc. does not have any upcoming earnings scheduled.
There is no upcoming split for AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc..
AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc. is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCPK.